Damora Therapeutics share price logo

Damora Therapeutics

NASDAQ: DMRA

Small Cap

$20.66

+0.39

(+1.92%)

as on

Damora Therapeutics Stock Performance

as on September 26, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $19.83
    $20.71
    downward going graph

    4.02%

    Downside

    0.24%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Damora Therapeutics share price movements today

Previous Close
$20.27
Open
$20.18
Volume
1.6M
Market Cap
$1.3B
Day's Low - High
$19.83 - $20.71

Damora Therapeutics Historical Returns

1 Month Return
-32.02 %
3 Month Return
-18.53 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Damora Therapeutics Stock Fundamentals & Key Indicators

Check Damora Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

-122.42

Dividend Yield

0.00%

PE Ratio (TTM)

-0.16

Industry PE ratio

-8.07

PEG Ratio

0.00015495234997305314

Return On Equity TTM

-82.56%

Damora Therapeutics Stock Valuation

Track how Damora Therapeutics P/E has moved over time to understand its valuation trends.

Damora Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-1.48x)

December 31, 2021

Industry (-8.07x)

December 31, 2025

Today (-0.15x)

December 31, 2025

Highest (-0.15x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.15x

Damora Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Damora Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
StrongBuy$1.3BNA-0.160.00%0.00%
Neutral$77.8B-53.76%-24.41-12.57%0.00%
StrongBuy$132.4B186.58%30.1686.04%0.00%
Buy$82.8B23.34%19.0184.86%0.46%

Analyst Recommendation on Damora Therapeutics Stock

Based on 7 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 7 analysts, 100% of analysts recommend a 'BUY' rating for Damora Therapeutics. Average target price of $46.6666666666667

Indian Investors' Interest in Damora Therapeutics Stock

Search interest for Damora Therapeutics Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Damora Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
-
0
0
Operating Income
-13
-13
-11
-5
-5
-5
-4
-201
-30
-34
EBITDA
-13
-12
-10
-7
-6
-5
-5
-200
-27
-34
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-14
-12
-10
-8
-6
-5
-5
-200
-27
-30
Income Tax Expense
-
-
-
-
-
-
0
0
0
0
Net Income
-14
-12
-10
-8
-6
-5
-5
-200
-27
-31
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Damora Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
0
0
0
0
0
0
-
Operating Income
-12
-38
-33
-52
-61
-36
-16
-210
EBITDA
-12
-38
-33
-51
-61
-37
-21
-209
Interest Expense
2
-
-
-
-
-
-
-
Depreciation
-
0
0
0
0
0
0
0
Income Before Tax
-15
-36
-34
-51
-61
-38
-21
-209
Income Tax Expense
-
-
-
-
-
-
0
0
Net Income
-15
-36
-34
-51
-61
-38
-21
-209
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Damora Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Dec 2025
Mar 2026
Jun 2026
Net Income
-14
-12
-10
-8
-6
-5
-5
-200
-27
-31
Operating Cash Flow
-11
-9
-7
-8
-11
-5
-4
0
-20
-21
Investing Cash Flow
14
1
3
8
9
5
6
-17
-
-
Financing Cash Flow
0
0
2
0
-
-
-
266
295
29
Change in Cash
4
-7
-2
0
-1
0
1
250
275
7

Damora Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-15
-36
-34
-51
-61
-38
-21
-209
Operating Cash Flow
-13
-19
-38
-52
-42
-36
-18
-6
Investing Cash Flow
-
0
-
-48
12
22
11
-17
Financing Cash Flow
42
-
187
-
0
2
-
266
Change in Cash
30
-19
152
-101
-29
-11
-7
243

Mutual Funds that own Damora Therapeutics Stock

Check out the Mutual Funds with significant holdings in Damora Therapeutics.

Funds
Holdings
Shares Held
Fidelity Mt. Vernon Street Trust
4.398335%
2715335
Fidelity Securities Fund
2.51496%
1552624
Fidelity Select Portfolios
1.546207%
954559
Fidelity Advisor Series VII
0.936481%
578142
Fidelity Capital Trust
0.653108%
403200

Global Institutional Holdings in Damora Therapeutics

Funds
Holdings
Peter Harwin
14.11%
Fidelity Mt. Vernon Street Trust
4.4%
Peter Kolchinsky
3.89%
Andreas Halvorsen
3.74%
iShares
2.89%

Insights on Damora Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, DMRA stock has moved up by 368.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 102.7% return, outperforming this stock by 58.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 343.6%

About Damora Therapeutics

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company’s lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
OrganisationDamora Therapeutics
HeadquartersBuilding 23, Waltham, MA, 02453, US
IndustryBiotechnology
CEOJennifer A. Jarrett
E-voting on sharesClick here to vote

Key Management of Damora Therapeutics

Name

Title

Ms. Jennifer A. Jarrett M.B.A.

CEO, President & Director

Mr. Ulf J. Nilsson Ph.D.

Co-Founder

Dr. Hakon Leffler M.D., Ph.D.

Co-Founder

Prof. Tariq Sethi B.Sc., FRCP, M.A., M.D., Ph.D.

Co-Founder

Mr. Brian Burkavage CPA

Senior VP of Finance, Principal Financial & Accounting Officer

Mr. Sherwin Sattarzadeh

Chief Operating Officer

Dr. Becker Hewes M.D.

Chief Medical Officer

Mr. Garrett Winslow Esq.

Senior VP, General Counsel & Corporate Secretary

FAQs

What is Damora Therapeutics share price today?

Damora Therapeutics share price today is $20.66 as on at the close of the market. Damora Therapeutics share today touched a day high of $20.71 and a low of $19.83.

What is the 52 week high and 52 week low for Damora Therapeutics share?

Damora Therapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Damora Therapeutics stock price today i.e. is closed at $20.66,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Damora Therapeutics's market capitalisation today?

Damora Therapeutics market capitalisation is $0.00T as on .

How to invest in Damora Therapeutics Stock (DMRA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Damora Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Damora Therapeutics Shares that will get you 0.0726 shares as per Damora Therapeutics share price of $20.66 per share as on September 26, 2026 at 8:46 am IST.

What is the minimum amount required to buy Damora Therapeutics Stock (DMRA) from India?

Indian investors can start investing in Damora Therapeutics (DMRA) shares with as little as ₹95.8125 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.13 in Damora Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Damora Therapeutics share’s latest price of $20.66 as on September 26, 2026 at 8:46 am IST, you will get 0.4840 shares of Damora Therapeutics. Learn more about fractional shares .